A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis
SA Mitchell, DS Bansi, N Hunt, K Von Bergmann… - Gastroenterology, 2001 - Elsevier
Background & Aims: Ursodeoxycholic acid (UDCA) is used for the treatment of cholestatic
liver diseases including primary biliary cirrhosis (PBC) for which it has a positive effect on …
liver diseases including primary biliary cirrhosis (PBC) for which it has a positive effect on …
[引用][C] A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis
SA MITCHELL, DS BANSI, N HUNT… - … (New York, NY …, 2001 - pascal-francis.inist.fr
A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis
SA Mitchell, DS Bansi, N Hunt, K Von Bergmann… - …, 2001 - gastrojournal.org
Abstract Background & Aims: Ursodeoxycholic acid (UDCA) is used for the treatment of
cholestatic liver diseases including primary biliary cirrhosis (PBC) for which it has a positive …
cholestatic liver diseases including primary biliary cirrhosis (PBC) for which it has a positive …
A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis
SA Mitchell, DS Bansi, N Hunt… - …, 2001 - pubmed.ncbi.nlm.nih.gov
Background & aims Ursodeoxycholic acid (UDCA) is used for the treatment of cholestatic
liver diseases including primary biliary cirrhosis (PBC) for which it has a positive effect on …
liver diseases including primary biliary cirrhosis (PBC) for which it has a positive effect on …
A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
SA Mitchell, DS Bansi, N Hunt, K Von Bergmann… - …, 2001 - europepmc.org
Methods Twenty-six patients with PSC were randomized to high-dose (20 mg/kg daily)
UDCA or placebo. Cholangiography and liver biopsy were performed at entry and after 2 …
UDCA or placebo. Cholangiography and liver biopsy were performed at entry and after 2 …
A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
SA Mitchell, D Bansi, N Hunt, K Von Bergmann… - …, 2001 - ora.ox.ac.uk
BACKGROUND and AIMS: Ursodeoxycholic acid (UDCA) is used for the treatment of
cholestatic liver diseases including primary biliary cirrhosis (PBC) for which it has a positive …
cholestatic liver diseases including primary biliary cirrhosis (PBC) for which it has a positive …
[PDF][PDF] LIVER, PANCREAS, AND BILIARY TRACT
GASTROENTEROLOGY, 2001 - academia.edu
Background & Aims: Ursodeoxycholic acid (UDCA) is used for the treatment of cholestatic
liver diseases including primary biliary cirrhosis (PBC) for which it has a positive effect on …
liver diseases including primary biliary cirrhosis (PBC) for which it has a positive effect on …
[引用][C] A preliminary trial of high-dose urusodeoxycholic acid in primary sclerosing cholangitis
M SA - Gastroenterology, 2001 - cir.nii.ac.jp
[引用][C] A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis
SA Mitchell, DS Bansi, N Hunt, K Von Bergmann… - Gastroenterology, 2001 - cir.nii.ac.jp
[PDF][PDF] LIVER, PANCREAS, AND BILIARY TRACT
GASTROENTEROLOGY, 2001 - academia.edu
Background & Aims: Ursodeoxycholic acid (UDCA) is used for the treatment of cholestatic
liver diseases including primary biliary cirrhosis (PBC) for which it has a positive effect on …
liver diseases including primary biliary cirrhosis (PBC) for which it has a positive effect on …